SCHEMBL20219291

SCHEMBL20219291

CCCCNc1nc(N(C(=O)OC(C)(C)C)C(O)OC(C)(C)C)ncc1OCc1cccc(C(=O)OC)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TLR8 Q9NR97 1/20 0.41
▸ TLR7 Q9NYK1 1/20 0.41
▸ MRGPRX4 Q96LA9 6/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ PPIA P62937 1/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP4F2 P78329 1/20 0.34
▸ CYP4A11 Q02928 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ CCR5 P51681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21769120 0.90 CYP1A2 (0.41) TLR8TLR7CYP1A2CYP2D6CYP3A4
SCHEMBL15469708 0.89 TLR8 (0.44) TLR8TLR7MRGPRX4RAB9ASMN1; SMN2
SCHEMBL20418680 0.80 HTR2A (0.34) TLR8
SCHEMBL13195812 0.78 TLR7 (0.59) TLR8TLR7MRGPRX4RAB9ASMN1; SMN2
SCHEMBL13195019 0.77 TLR7 (0.46) TLR8TLR7CYP1A2CYP2D6CYP3A4
SCHEMBL20219584 0.70 CYP1A2 (0.34) TLR8TLR7CYP1A2CYP2D6
SCHEMBL15469709 0.69 CYP2D6 (0.42) TLR8TLR7MRGPRX4CYP1A2CYP2D6
SCHEMBL20219392 0.69 CYP1A2 (0.46) TLR8TLR7MRGPRX4RAB9ASMN1; SMN2
SCHEMBL15469710 0.69 TLR8 (0.39) TLR8TLR7CYP1A2CYP2D6CYP3A4
SCHEMBL15469973 0.68 CYP1A2 (0.54) TLR8TLR7MRGPRX4RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback